BamSEC and AlphaSense Join Forces
Learn More

Ernexa Therapeutics Inc. – Material Contracts

NASDAQ: ERNA    
Share price (9/24/26): $3.62    
Market cap (9/24/26): $5.909 million

Material Contracts Filter

EX-10.1
from 8-K 23 pages Ernexa Therapeutics Inc. 2026 Omnibus Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 14 pages Warrant Agent Agreement
12/34/56
EX-10.1
from 8-K 43 pages Form of Securities Purchase Agreement
12/34/56
EX-10.20
from S-1/A 14 pages Warrant Agent Agreement
12/34/56
EX-10.19
from S-1/A 43 pages Securities Purchase Agreement
12/34/56
EX-10.20
from S-1/A 14 pages Warrant Agent Agreement
12/34/56
EX-10.19
from S-1/A 42 pages Securities Purchase Agreement
12/34/56
EX-10.19
from S-1 42 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 8-K 12 pages Pre-Funded Common Stock Purchase Warrant Ernexa Therapeutics Inc
12/34/56
EX-10.2
from 8-K 14 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 43 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 7 pages Promissory Note
12/34/56
EX-10.1
from 8-K 7 pages Promissory Note
12/34/56
EX-10.11
from 10-Q 2 pages Sublease Termination Agreement
12/34/56
EX-10.10
from 10-Q 27 pages Exclusive License and Collaboration Agreement
12/34/56
EX-10.3
from 8-K 15 pages Pre-Funded Common Stock Purchase Warrant Eterna Therapeutics Inc
12/34/56
EX-10.2
from 8-K 14 pages Pre-Funded Common Stock Purchase Warrant Eterna Therapeutics Inc
12/34/56
EX-10.1
from 8-K 16 pages Registration Rights Agreement
12/34/56
EX-10.8
from 8-K 2 pages The Undersigned Intends to Enter Into an Exchange Agreement (The “Exchange Agreement”) With Eterna Therapeutics Inc. (The “Company”), Pursuant to Which the Undersigned Will Exchange (The “Exchange”) Certain Convertible Notes Issued by the Company and/or Warrants to Purchase Shares of the Company’s Common Stock, Par Value $0.005 Per Share (The “Common Stock”), Held by the Undersigned for Shares of Common Stock
12/34/56
EX-10.7
from 8-K 6 pages Support Agreement
12/34/56